Current Funding Opportunities

To visit the NCI grant site, click here


Use your device's search function to find a specific disease or funding source. 


Aging


Paul B. Beeson Emerging Leaders Career Development Award in Aging 

This Funding Opportunity Announcement (FOA) invites early-stage physician and other health-professional investigators with a commitment to aging to apply for this award to advance their research and leadership skills in their specialty and in the broader field of aging and geriatrics research. 

Application Deadline: October 19, 2017

Breast 

Basser Center for BRCA External Research Grant Program

The Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center announces the Basser External Research Grant Program, which focuses on projects that have the potential to advance the care of individuals living with BRCA1 and BRCA2 mutations. Research grant applications in basic science, prevention, early detection, or targeted therapeutics and relevant to the study of BRCA1/2 will be considered.

LOI Due: November 13, 2017

Learn More>>

Avon Breast Cancer Crusade 2017 Funding 

These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.

Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.



Colorectal


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 


This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.

 

Lung 


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 

 
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.


Melanoma


Melanoma Research Alliance

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for high-impact pre-clinical, translational, and early clinical research that has the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment. This cycle, proposals will be accepted for Team Science Awards, Young Investigator Awards, and Academic-Industry Partnership Awards for Established Investigators.

Application Deadlines: November 17, 2017: Young Investigator Award and Academic-Industry Partnership Award proposals 

Ovarian

Department of Defense Ovarian Cancer Research Program Funding Opportunities

FY17 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February 2017.  Pre-application and application deadlines will be available when the Program Announcements are released. 

Clinical Development Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Investigator-Initiated Research Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Ovarian Cancer Academy Award – Early-Career Investigator
Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline.  A letter attesting to eligibility is required.

Pilot Award
Established Investigator:  Independent investigator for whom it has been more than 3 years since his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent; or
Early-Career Investigator:  Investigators must meet one of the following criteria by the application submission date: Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.) OR In a postdoctoral research position (Ph.D), or clinical fellowship (M.D.), or equivalent.  

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 


This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.

 

Pancreatic


The Pancreatic Cancer Detection Consortium (U01)

This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions.

Application Due Dates: April 6, 2018

Learn More>>

Pediatric


Matthew Larson Foundation for Pediatric Brain Tumor Research Grants

The Matthew Larson Foundation for Pediatric Brain Tumor Research seeks to fund translational and clinical projects in Pediatric Brain Tumor Research. Over the past 10 years, the Foundation provided nearly $3 million in funding for a total of 37 important research projects at institutions across the U.S. including Dana Farber, Memorial Sloan Kettering, UCSF, Johns Hopkins, Columbia, Weill Cornell, and UCLA.

Successful applicants will be invited to submit a formal application after the Letter of Intent (LOI) is reviewed.  

LOI Due: November 1, 2017

AVON 

Avon Breast Cancer Crusade 2017 Funding 

These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.


Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.


The Howard Hughes Medical Institute


The Hanna H. Gray Fellows Program Competition

The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals who are from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those from disadvantaged backgrounds, early in their careers. The Hanna H. Gray Fellows Program supports early-career life scientists in academic labs across the U.S. The 2018 competition is now open.

Application Deadline: January 10, 2018

NIH/NCI

Clinical and Epidemiological Research on Chronic Disease in the Caribbean
NCI Center for Global Health (CGH) helps reduce the global burden of cancer by strengthening research capacity through funding and training. The purpose of this Funding Opportunity Announcement (FOA) is to support US-Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region that are aligned with existing publicly available US datasets. 

Application Deadlines: November 15, 2017, November 15, 2018, November 15, 2019


Clinical and Translational Exploratory/Developmental Studies (R21)  
This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials. 

Application Receipt/Submission Date(s): November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization. 

Learn More>> 



Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) 
This Funding Opportunity Announcement (FOA) encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer. 

Application Receipt/Submission Date(s): November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization. 

Learn More>> 



Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)   
This funding opportunity announcement (FOA) invites applications for research on cancer epidemiology, genomics, and risk assessment. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research. 

Application Receipt/Submission Date(s): November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization. 

Learn More>> 



Emerging Questions in Cancer Systems Biology (U01)   
This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for Research Projects that utilize systems biology approaches to address emerging questions in cancer initiation, progression, and treatment.

Application Receipt/Submission Date(s): November 24, 2017; June 22, 2018; November 23, 2018, by 5:00 PM local time of applicant organization.

Learn More>> 



Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01) 
This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. 

Application Receipt/Submission Date(s): November 30, 2017; May 30, 2018; November 30, 2018, by 5:00 PM local time of applicant organization. 

Learn More>>



Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)
The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement (U01) applications that propose studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. 

Application Due Date: December 14, 2017 

Learn More>> 



Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.

Application Due Date: January 8, 2018

Learn More>>


Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)   

The main goals for this initiative include: a) Development of racially/ethnically diverse PDX models; b) Development of methods for preclinical testing of single agents and drug combinations; and c) Conducting response studies of PDX models, primarily from racially/ethnically diverse populations, to develop novel therapeutic strategies.


Application Due Date: January 18, 2018

Learn More>>



Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) 

The goals for this FOA include the development of translational research programs focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs, with the expectation that the research programs will become competitive for a full Specialized Programs of Research Excellence (SPORE).


Application Due Date: January 18, 2018

Learn More>>



Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for  developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers. 



Application Due Date: 

January 29, 2018 


Learn More>>

Pancreatic Cancer Action Network


The Pancreatic Cancer Detection Consortium (U01)  
This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. 

Application Due Date: April 6, 2018 

Learn More>>

Pershing Square Sohn Cancer Research Alliance

2018 Prize for Young Investigators in Cancer Research

The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area scientists, enabling them to continue to pursue explorative, high-risk/high-reward cancer research at a stage when traditional funding is lacking.

The deadline to submit the Letter of Intent is November 6, 2017

For more details on the application process, including the full eligibility criteria, and for more details on The Pershing Square Sohn Cancer Research Alliance, please visit: www.psscra.org.

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants. 

Click to see all the Internal Grants from 2012-2016.



Yale and the Liberia Mi nistry of Health and Liberia College of Physicians and Surgeons Opportunity 

Yale and the Liberia Ministry of Health and Liberia College of Physicians and Surgeons are seeking INTERNAL MEDICINE AND ITS SUBSPECIALTIES (cardiology, gastroenterology, pulmonary, heme/onc, ID) and lab medicine to serve in Liberia. The Liberia Ministry of Health, in conjunction with the World Bank, has established the Health Workforce Program (“HWP”), a seven-year project, which aims to bolster and expand the health education infrastructure and healthcare workforce necessary to create a high quality and sustainable healthcare system in Liberia. Yale School of Medicine has been identified to help develop a sustainable model to train specialists in internal medicine.

Interested applicants are encouraged to submit a copy of their CV to asghar.rastegar@yale.edu along with a one-page cover letter. Currently accepting applications for the 2017-2018 academic year (July 2017-June 2018).

Learn More>>




National Science Foundation Major Research Instrumentation Program 2018

This program supports the acquisition, through purchase, upgrade, or development of state-of-the-art major instrumentation for research, research training, and integrated research/education activities. Yale University may submit up to three (3) proposals for the acquisition or development of instrumentation.

Internal Deadline: October 24, 2017





Women's Health Research at Yale 2017–18 Pilot Project Program

On behalf of Dr. Carolyn M. Mazure and Women’s Health Research at Yale, we are pleased to announce the Pilot Project Program Request for Letters of Intent. 
 
Women’s Health Research at Yale’s 2017-2018 Pilot Project Program offers the following research funds: 
  • Pilot Project Awards: Up to $35,000 over one or two years for research designed to meet a pressing need in women’s health or in understanding sex differences, and with a clearly described path to direct clinical or public health utility
  • Wendy U. and Thomas C. Naratil Pioneer Award: up to $50,000 in funding over one or two years to initiate new investigations that are highly inventive or close to a major breakthrough in advancing women’s health or knowledge of sex differences
Application Deadline: October 26, 2017




Nominations for Annual YCC Awards: Yale Cancer Center is pleased to announce our call for nominations for our annual awards in the areas of excellence in research and clinical care. Each award will be announced at the Yale Cancer Center Conclave in January. The nomination deadline for all awards is Friday, October 27. 

Yale Cancer Center Research Prizes: Research Prizes will be awarded in support of excellence in the areas of basic science, clinical research, translational research, and cancer prevention and control. Awards will be chosen in each area to recognize a paper that is considered to have had the greatest impact on the field this year. The applicant must be a current member of the Cancer Center and science in the publication must be cancer-focused. Please submit a PDF of your best publication (publication date from October 2016 to October 2017). To be eligible, you must be either the first or last author of the publication. Email your publication to anna.raso@yale.edu.




Program in Innovative Therapeutics for Connecticut's Health (PITCH) 

The Program in Innovative Therapeutics for Connecticut’s Health (PITCH) fuels target validation based on innovative research ideas born in laboratories from Yale University and the University of Connecticut. With a grant from the State of Connecticut’s Bioscience Innovation Fund, this three-year, $10 million dollar program provides translational research resources to generate prototype therapeutics that address unmet clinical needs. 

Deadline for Application: November 15, 2017

Please contact Jane Merkel for more information, janie.merkel@yale.edu

SPORE in Lung Cancer Program Awards

Learn More>>

LungSPORE@yale.edu     



Lion Heart Grants
  • Funding amount based on fundraising annually done by Lion Hearts
  • For Yale Cancer Center members only 
  • To support breast cancer research
  • Committee of Yale Cancer Center members and Lion Heart members review and select grant recipients
  • Administered by Anees Chagpar

V Foundation Pediatric Cancer Grants

  • ONE NOMINEE TO APPLY FOR EITHER THE V SCHOLAR OR TRANSLATIONAL AWARD
  • The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the department chair or other senior research administrative official who is responsible for the internal nominee 
  • Applicant must be employed at a non-profit research institution 
  • Administered by Gary Kupfer  

American Cancer Society Institutional Research Grants

  • $30,000 for one year
  • For assistant professors only
  • Prior national research grant disqualifies
  • Four awards per year
  • Usually reviewed in December
  • Administered by Joann Sweasy


Rausch Foun dation Grants in Community Health

  • $30,000-$50,000 for one year
  • Population science focus
  • Priority to projects with impact to New Haven
  • Administered by Melinda Irwin 


YCC Pilot Grants

  • $50,000 for one year
  • All YCC members eligible to apply
  • Specific project proposed by individual investigator
  • Seven or eight awards per year, distributed among all seven research programs
  • Usually reviewed in Spring
  • Administered by Joann Sweasy
  • For more information, please contact Jan Zulkeski


T-TARE Award

  • Up to $200,000 for one year
  • For teams of investigators
  • Research with a translational focus
  • Major goal is to generate data and evidence of collaboration for multi-investigator grant application
  • Administered by Roy Herbst


Yale Discovery Fund Grants 

  • $450,000 to be spent over three years
  • High-risk/high-reward cancer research
  • Multidisciplinary collaborative research
  • Hope to fund 3 – 4 each year
  • Administered by Dan DiMaio


Leslie Warner Postdoctoral Fellowship

  • ~$42,000 for one year
  • Fellows working in YCC member laboratories eligible to apply
  • Must be in first year of fellowship
  • Four awards every other year
  • Usually reviewed in fall
  • Review organized by Karen Anderson